Back to User profile » Dr Isamu Okamoto

Papers published by Dr Isamu Okamoto:

Study Protocol

Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)

Tachihara M, Tsujino K, Ishihara T, Hayashi H, Sato Y, Kurata T, Sugawara S, Okamoto I, Teraoka S, Azuma K, Daga H, Yamaguchi M, Kodaira T, Satouchi M, Shimokawa M, Yamamoto N, Nakagawa K

Cancer Management and Research 2021, 13:9167-9173

Published Date: 14 December 2021

Review

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives

Inoue H, Okamoto I

Lung Cancer: Targets and Therapy 2019, 10:161-170

Published Date: 3 January 2020

Review

Clinical development of nintedanib for advanced non-small-cell lung cancer

Takeda M, Okamoto I, Nakagawa K

Therapeutics and Clinical Risk Management 2015, 11:1701-1706

Published Date: 16 November 2015

Review

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Iwama E, Okamoto I, Harada T, Takayama K, Nakanishi Y

OncoTargets and Therapy 2014, 7:375-385

Published Date: 5 March 2014